Study Objectives: The interaction between homeostatic sleep pressure and circadian timing modulates the impact of sleep deprivation on cognition. We aimed to investigate how this interaction affects different cognitive functions.
Introduction
Insufficient sleep has an adverse impact on health and a wide range of cognitive functions [1] . While sleep deprivation can result in greater performance deficits on measures of particular cognitive domains, especially those assessing simple reaction time (RT) [2] , it is not fully understood how these task-specific vulnerabilities may be differentially affected by a combination of circadian and homeostatic factors.
Both increased time awake and circadian timing impact cognitive performance. When wake is extended beyond the normal 16-hour day, cognitive performance deteriorates [3] [4] [5] . Circadian timing can modulate performance outcomes both favorably and unfavorably. For instance, performance can be impaired at adverse circadian times even in well-rested participants [6] [7] [8] , or improved at favorable circadian times [6, 8] , even in sleepdeprived participants [9] . The wake maintenance zone (WMZ) is a 2-to 3-hour phase prior to the evening onset of melatonin secretion where the circadian system maximally promotes wakefulness [10, 11] and performance [6, 12] . While a recent study reported evidence of task-dependent effects when the circadian system is adversely affecting performance (i.e. during times of circadian misalignment during a simulated night shift study) [13] , no study has examined task-dependent effects when the circadian system is promoting performance, that is, during the WMZ.
During sleep deprivation, the magnitude of impairment is generally greater on tasks measuring simpler aspects of cognition, compared to tasks that require complex or integrative cognitive operation. In a meta-analysis of 70 studies, where tests were grouped into six broad cognitive domains, and outcomes reported as either accuracy, RT, or attentional lapses [2] , performance on simple attention tasks like the Psychomotor Vigilance Test (PVT) showed the greatest vulnerability to sleep deprivation, with large effect sizes for lapses and RT. Performance on more complex tasks was comparatively less vulnerable to 24-48 hours sleep deprivation. The extent to which this taskdependent effect of sleep deprivation is observed during the WMZ, where performance is optimal, is unknown. Moreover, it is of particular importance given that cognitive function following one night of sleep deprivation is commonly tested in either the early morning (~22-26 hours post-wake) or evening (~34-37 hours post-wake), corresponding to the circadian nadir and peak in performance, respectively. In addition, some studies compare sleep deprivation to well-rested conditions at the same circadian or clock time [14, 15] , while others do not [16] [17] [18] . In tests scheduled 22-26 hours post-wake, processing speed [19] , working memory [20, 21] , and complex attention, such as tests of response inhibition [22] , are adversely impacted by one night of sleep deprivation. In tests scheduled 34-37 hours post-wake, verbal memory [23, 24] , working memory [25] , social decisionmaking [26] , and complex attention [27] [28] [29] are impaired. In protocols where the same test was completed in the morning and evening, some have reported no differences between morning and evening on working memory [25] and response inhibition [18] , while one group found improved performance on tests of working memory and visual discrimination at 38 hours of wakefulness relative to 25 hours [30] . Understanding whether these differences are due to task-dependent effects observed in the WMZ, or due to differences in study design, timing of test administration, and test characteristics is challenging.
We sought to address this challenge by assessing the impact of sleep deprivation on multiple tasks in both the morning and evening, compared to when well-rested at the same circadian time (i.e. 24 hours earlier). For evening tests, we will ensure task administration is within the WMZ. In addition, to minimize confounding aspects of task characteristics, we employed a cognitive battery of four tests of attention (simple and complex) and memory (recognition and working) with comparable duration and near-identical visual presentation.
Methods

Participants
Twenty-three healthy young adults (18 men, 5 women), aged 25.43 ± 5.67 (M ± SD) years, participated. Ethical approval for all procedures was obtained from the Monash University Human Research Ethics Committee (CF14/2790 -2014001546). Participants gave written informed consent. Participant eligibility criteria included: fluency in English, no shift work (5 or more hours worked between 10:00 pm and 07:00 am) within the last 3 months, no transmeridian travel across three or more time zones in the past month, a body mass index between 18.0 and 29.9 kg/m 2 , no history of medical, psychiatric or sleep disorders, and no reported use of illicit drugs within the last year, or consumption of caffeine exceeding 300 mg/day or alcohol exceeding 14 standard units/week. Women were not currently pregnant or using hormonal contraception, and were studied in the laboratory during the follicular phase of their menstrual cycle. All participants were deemed medically and psychologically healthy following a full medical history and examination by a physician, including electrocardiogram and blood and urine tests, and an interview with a clinical psychologist. They refrained from consuming alcohol and caffeine, or using nicotine, supplements, or prescription or non-prescription drugs in the 3 weeks prior to admission to and throughout the laboratory study. Compliance was verified by a urine toxicology screen and breathalyzer assessment on their arrival for the laboratory assessment. All reported habitual bedtimes between 09:30 pm and 01:00 am, habitual wake times between 05:30 am and 09:00 am, and sleep duration between 7 and 9 hours with no more than one nap per week. A flowchart of participant recruitment can be found in the Supplementary Material (S1).
Pre-laboratory protocol
For 3 weeks prior to the laboratory assessment, each participant wore an Actiwatch Spectrum (Philips Respironics, BMedical, QLD, Australia), completed a daily sleep diary, and made a timestamped call-in message when they woke and when they went to bed. For the first week, participants were free to select their bed and wake times. For the 2 weeks immediately prior to the laboratory assessment, they adhered to a strict 8:16 hours sleep:wake schedule, with a consistent bed and wake time. Compliance with this schedule was verified by actigraphy and their call-ins. the first sleep episode. Participants were excluded if a sleep disorder was identified.
The laboratory protocol ( Figure 1 ) included 2 baseline days, 40 hours of continuous wakefulness under constant routine (CR) conditions and 2 recovery days. During the baseline days, participants maintained their structured 8:16 hours sleep:wake schedule from their last 2 weeks of at-home monitoring. Recovery sleep opportunities were extended to 12 hours, though participants were permitted to get up earlier if they were unable to sleep. Light levels were strictly controlled throughout the study: mean maximum ambient light during baseline and recovery wake episodes was ~102 ± 37 lux (horizontal plane) and ~45 ± 21 lux (vertical plane), and ~3 ± 1 lux (horizontal) and ~1 ± 3 lux (vertical) during CR and the last 5 hours of the second baseline day. Lights were turned off during sleep episodes. Ambient lighting illuminance was measured on each day of the protocol at four locations directly under light panels in the suite at a height of approximately 1.8 m using a light meter (Tektronix J17 Luma Color, Oregon). Lighting was generated from ceiling-mounted Philips 4100K fluorescent bulbs (Master TL5 HE 28W/840 cool lights, Philips Lighting, Amsterdam, Netherlands), covered with neutral density filters (3-stop LEE Filters, Lightmoves, Noble Park, Australia), which provided broad-spectrum white light with a peak of 545 nm and correlated color temperature (CCT) of 3968K (UPRTek MK350N Spectrometer, Taiwan). During wake periods other than the CR, participants were free to move around the suite and engage in quiet activities when not completing tests.
Constant routine
Participants woke to CR conditions after their second baseline night. The CR protocol is designed to minimize or remove environmental time cues that influence the rhythms of the participant's body clock [31] . Throughout the 40 hour CR, participants remained in bed in a semi-recumbent posture, and were not permitted to make any significant postural changes. They consumed hourly isocaloric snacks (a quarter sandwich, with 60 mL of water and 40 mL of apple juice), with a macronutrient content in line with the Australian Dietary Guidelines 2013 [32] . Urine voids and bowel movements were completed in bed with either a metal urinal or bedpan. To ensure they remained awake, participants were continuously monitored by a staff member in the suite, except during urine voids and bowel movements. A computer was wheeled over the bed for participants to complete tests during the CR; this was designed to allow participants to comfortably view the screen and complete the tests while maintaining constant posture.
Cognitive testing
Participants completed one practice of each test on the first baseline day. Previous research has shown that performance on the Cogstate Brief Battery (CBB) stabilizes after one practice session (Cogstate, Melbourne, Australia) [33] [34] [35] .
Participants completed the CBB four times during the CR, shown by the inverted triangle in Figure 1 . Two administrations were in the morning, 24 hours apart, at 3 hours and 27 hours post habitual wake, and two were in the evening, also 24 hours apart, at 13 hours and 37 hours post habitual wake (equivalent to 11:00 am and 09:00 pm for a participant with an 08:00 am waketime). The CBB comprises four computerized tests that take approximately 10-12 minutes in total to administer. The tests are presented in the same sequence, with near-identical visual presentation, and have standard instructions that appear on the screen for the experimenter to read to the participant. In each test, participants are instructed to attend to a facedown playing card in the center of the screen, and respond to a question specific to the task when the card flips over. Participants were asked to respond as quickly and accurately as possible in all tests by clicking the left mouse button for "Yes" or the right mouse button for "No" with the hand they usually use to operate a mouse. The CBB has been validated as a measure of cognitive impairment in neurodegenerative conditions [33, 36] , pharmacologically-induced sedation [37, 38] , and sleep deprivation [39] .
The four tests comprising the CBB largely assess the domains of attention and memory [40] [41] [42] .The tasks are as follows:
Attention. Detection (DET) task-a simple RT test. Participants are asked "Has the card turned over?" and must press the "Yes" button as quickly as possible when it does. The task continues until either 25 correct responses are recorded, or the maximum time of 2 minutes is reached. Identification (IDN) task-a choice RT test. Participants are asked "Is the card red?" and must press the "Yes" button if it is, and the "No" button if it is not. The task continues until 35 correct responses are made, or until the maximum time of 2 minutes is reached.
For both DET and IDN, anticipatory responses (those made before the card flips over) and timeouts (responses longer than 3.5 s) are considered incorrect trials and removed from the analysis. The primary outcome of each task is RT in milliseconds. These tasks measure different aspects of attention. DET, as a simple RT task, presents a single stimulus to which participants are required to make a single response: this measures vigilant attention [41, 43] . IDN, as a two-choice RT task, requires participants to first identify which of two stimuli has been presented, then select and make the correct response from two alternatives. This reflects both information processing speed and more complex attention [2, 41, 43] .
Memory. One Card Learning (OCL) task-Participants are asked "Have you seen this card before in this task?"; when the card flips over, they must press the "Yes" button if the card has been presented previously, and the "No" button if not. Six randomly selected cards will repeat throughout the task; the others are used as non-repeating distractors interspersed between them. The task continues until either 42 correct responses are made, or the maximum time of 3 minutes is reached. One Back (ONB) task-Participants are asked "Is this card the same as that on the immediately previous trial?". When the card flips over, participants must press the "Yes" button if it is the same as the card presented immediately before it, and the "No" button if it is not. The task continues until either 42 trials have been responded to (correctly or incorrectly), or until the maximum time of 3 minutes is reached.
The primary outcome of both OCL and ONB is the percentage of correct responses (accuracy), expressed as a decimal with a maximum value of 1.0 (e.g. 90% correct responses would be expressed as an accuracy of 0.9). These tasks assess different aspects of memory. As an n-back task, ONB assesses working memory [21, 41] , while OCL assesses recognition memory [33, 34] .
KSS and PVT.
From 2 hours after waking to CR, participants completed a bi-hourly computerized test battery containing the Karolinska Sleepiness Scale (KSS) and a visual PVT. The KSS was also administered by itself on the alternate hour. The KSS is a one-item questionnaire that asks participants to indicate on a scale of 1-9 how sleepy they have been feeling over the previous 5 minutes [44] . The modified version with descriptors identified on each point was utilized [45] . The PVT required participants to monitor a white rectangle centered on the screen, and press a button on a handheld response box with their dominant thumb as quickly as possible each time a stopwatch stimulus appeared and began counting up from zero. Once the participant responded, the stopwatch briefly displayed their RT in milliseconds before resetting. The stimulus appeared at random intervals between 2 and 10 seconds after the previous response. If the participant made no response within 5000 ms, an alerting tone played. Any response <100 ms was removed from the data during cleaning, including anticipatory responses. Mean response time and number of lapses were calculated.
Melatonin measurement
Blood samples were taken each hour via an in-dwelling intravenous cannula to assess participants' plasma melatonin levels, a marker of circadian timing [46] . The cannula was inserted into either a forearm or antecubital vein approximately 1 hour after waking to CR. Samples were centrifuged at 2700 rpm for 10 minutes at 4°C to separate the plasma layer, either immediately or after temporary refrigeration at 4°C. A 1 mL aliquot was taken from each sample, snap frozen in dry ice, and stored at −20°C until assayed. Total blood plasma melatonin concentration was determined at the Adelaide Research Assay Facility by reverse-phase C-18 column extraction of 500 µL plasma, followed by double antibody radioimmunoassay using standards and reagents supplied by Buhlmann Laboratories (RKMEL-2, Buhlmann Laboratories AG, Schönenbuch, Switzerland). This assay is based on the Kennaway G280 anti-melatonin antibody [47, 48] and [125I]2-iodomelatonin as the radioligand and follows the protocol provided by Buhlmann. The limit of detection of the assay using 500 µL of extracted plasma was 1.0 pg/mL. Samples were sent in four batches. All samples from an individual were measured in a single assay. Samples were assayed in duplicate and the range of the intra-assay coefficients of variation was 5.5-9%. The range of the inter-assay coefficients of variation of the low concentration quality control was 5.3-13.3%; the range of the inter-assay coefficients of variation of the high concentration quality control was 7.3-17.7%.
Data analysis
Data were collected from 23 participants. KSS data includes all 23 participants. CBB data was collected from n = 21 participants (n = 1 lost due to failed data quality checks; n = 1 removed due to not completing all four test sessions). Following dim light melatonin onset (DLMO) assessment, evening task administration for n = 3 did not fall within the WMZ. These were removed from the CBB analyses, leaving a total of n = 18. PVT data are described for 14 participants only (of the 23 participants, n = 9 were lost due to technical difficulties with the task).
DLMO calculation
DLMO times were calculated for each participant as the time at which the concentration of plasma melatonin first exceeded 5 pg/mL, based on the melatonin conversion factor of 4.304778 [49] , using linear interpolation between the samples immediately prior to and after the threshold. Where possible, DLMO time was calculated from the first evening rise in melatonin levels observed during CR, and assigned a circadian phase of 0. Where DLMO was not accurately identified at this point (n = 4, due to missing samples), it was calculated during the second melatonin cycle near the end of the CR. In the 11 participants for whom it was possible to calculate both DLMO times, the times did not significantly differ, t(10) = 0.63, p = .54, and were highly correlated, r = 0.94. Tests were deemed to have occurred in the WMZ if they were begun in the 3-hour period prior to DLMO [9] , including those calculated to have begun within 5 minutes of DLMO (Figure 2) . Results on the CBB were only reported for those participants who completed the evening batteries within the WMZ.
Transformations
To normalize the distributions of the Cogstate data, a logarithmic base 10 transformation was applied to RT outcomes, and an arcsine square-root transformation was applied to the accuracy outcomes [42] . All PVT RTs were normalized with a reciprocal ((1/RT) * 1000) transformation. Lapses were transformed with a squareroot transformation [(n) + (n+1)] to normalize the distribution [50] .
Calculation of Cogstate composite scores
To express the magnitude of cognitive decline during sleep deprivation across tasks, and on a comparable scale, we calculated standardized RT and accuracy composite change scores for the Cogstate battery based on previously reported methodologies [38, 51] . This was calculated for morning (3 hours vs. 27 hours) and evening (13 hours and 37 hours) tests separately using the following equation:
Sleep Deprived Score Well Rested Score within-subjects
Change scores for RT tests were reversed such that a negative change score indicates decline from baseline on all tests. Change scores were standardized using a within-subjects SD [52] drawn from age-based normative data for the tests (Supplementary Table 1 ). An accuracy composite change score was calculated by averaging the standardized change scores on OCL and ONB, and a RT composite change score was calculated by averaging standardized change scores on DET and IDN. The accuracy composite thus reflects performance on memory tasks, while the RT composite reflects performance on attention tasks [42] .
Analyses
The effect of sleep deprivation on each performance measure was analyzed using a linear mixed model, as this approach accommodates missing data and inter-individual variability. Time awake was modeled as a fixed effect, and participant was modeled as a random effect. A compound symmetry covariance structure was used for all models except for DET and KSS, for which a first-order autoregressive covariance structure was used. For all models, the covariance structure that produced the lowest Schwarz Bayesian Information Criterion (BIC) value was used [53] . Pairwise comparisons were run post hoc to test for differences between well-rested and sleep-deprived performance in the morning and evening. Performance on the CBB tests was compared between 3 hours and 27 hours (morning) and 13 hours and 37 hours (evening). KSS scores, PVT mean RT and number of lapses were taken from the test session prior to each CBB administration: the morning PVT/ KSS tests were thus taken at 2 hours and 26 hours post-wake, and the evening tests at 12 hours and 36 hours post-wake. Cogstate composite scores were tested against a mean of zero with onesample t-tests. A false discovery rate (FDR) adjustment was used to control for familywise error [54, 55] 
Results
Cogstate battery results
Alertness-vigilance battery results
To validate that the protocol provided the expected circadianand wake-dependent changes, we analyzed the PVT data from the subset of participants with those data. Subjective and objective indices of alertness change were observed across the protocol, such that alertness was lowest during the biological night and highest during the first 16 hours of the CR ( Figure 5 ). PVT performance significantly declined with time awake (Figure 6 ): Post hoc tests showed mean RT was significantly greater at 26 hours relative to 2 hours awake, with a large effect size, p adj 
Discussion
Our findings show that the deterioration in cognitive performance during sleep deprivation is both task-and time-dependent. Simple, sustained attention, as measured by the PVT and DET, was significantly poorer following >24 hours of sleep deprivation compared to well-rested performance, regardless of whether testing occurred in the morning, or in the evening during the WMZ. In contrast, complex attention (IDN) and working memory (ONB) were impaired during sleep deprivation when tested in the morning (27 hours awake vs. a circadian matched wellrested baseline at 3 hours awake), but were preserved when tested in the evening during the WMZ (37 hours awake vs. a circadian matched well-rested baseline at 13 hours awake), despite the increased homeostatic sleep pressure at this time. Recognition memory (OCL) did not show an overall effect of sleep deprivation, yet showed evidence of the same pattern of results as complex attention and working memory: performance was poorer at 27 hours relative to 3 hours (a medium effect size of d = −0.57) but not at 37 hours relative to 13 hours (d = −0.20). Moreover, change in aggregated performance to reflect speed and accuracy across tasks following one night without sleep also differed with the time of testing: both speed and accuracy were impaired during morning testing, while speed slowed and accuracy was preserved during evening testing in the WMZ. Our findings are consistent with our earlier work investigating the impact of the WMZ on cognitive performance during 50 hours of sleep deprivation [9] . Here, vigilant attention (PVT) and information processing speed (the digit symbol substitution *Post hoc tests were not run on OCL as the main effect of time awake was not significant.
task [DSST] ) was improved in the WMZ, relative to performance earlier in the same day. We calculated the magnitude of change (Cohen's d) between well-rested and sleep-deprived performance in the WMZ in this study, and compared it to our current findings. For vigilant attention, the magnitude of change when sleep deprived and in the WMZ was comparable between studies: PVT raw RT (d = 1.04 for both studies) and lapses (d = 1.43 (current) and d = 2.04 [Shekleton et al.] ) were both poorer when sleep deprived, with large effect sizes [56] . DSST performance in the WMZ, however, was poorer when sleep deprived in our previous study (d = 0.52, a medium effect size) [57] , while performance on IDN, a task also considered to assess processing speed [41] , was not significantly impaired in the WMZ when sleep deprived, though the magnitude of the difference meets criteria for a small effect size (d = 0.34). This difference may be attributable to the tasks themselves: The performance outcome on the IDN is RT, a direct measure of processing speed, while performance on the DSST is the number of correct responses made within the task's 2-min time limit. While a reduced number of correct responses on the DSST may reflect participants responding more slowly and seeing fewer trials during sleep deprivation, this highlights the importance of considering task design when comparing results across and within studies. Our findings are also consistent with the meta-analysis by Lim and Dinges [2] . They reported that sleep deprivation resulted in the greatest impairment on simple RT measures, with large effect sizes (mean Hedges' g = −0.76 and −0.73 for lapses and RT, respectively), while speed and accuracy were also impaired on tasks of greater complexity, with medium effect sizes (mean Hedges' g ranging between −0.31 and −0.55). Morning performance on individual tests in this study followed this pattern: PVT performance and vigilant attention (DET) were most adversely impacted by sleep deprivation, with large effect sizes, while measures of complex attention/information processing and recognition memory deteriorated to a lesser extent, with medium effect sizes. In the WMZ, however, performance was undiminished on these measures and the accuracy composite score, while the PVT, vigilant attention, and the RT composite remained strongly impaired. These findings expand on those of the meta-analysis by highlighting the importance of considering the circadian timing of tests when measuring cognitive function during sleep deprivation. While it is hypothesized that cognitive improvement during the WMZ is due to an increased circadian drive for alertness to counter the rising pressure to sleep due to extended time awake [5, 58] , this is inconsistent with the finding that, in the WMZ during sleep deprivation, accuracy is maintained, but response speed is not. This may indicate that the impact of the WMZ is test specific, and potentially goes beyond simply promoting alertness (see below).
Our finding that tests of complex attention and working memory were vulnerable to sleep deprivation during the morning hours, but not during the WMZ, contrasts with previous results. In other studies, verbal memory, working memory, and complex attention were impaired during the evening following 34-36 hours of sleep deprivation [18, 24, 25, 28] . While this discrepancy may be due to task characteristics (i.e. our tasks were of shorter duration, which is known to be less sensitive to the effects of sleep deprivation [59] ), it is also possible that participants in previous studies were not tested in their WMZ, as the tests were scheduled relative to habitual wake time without a measure of circadian timing (WMZ). Our data highlight the need to better understand the potential task-dependent improvement in performance during the WMZ. Future studies may assess this with longer duration tasks, commonly used within the sleep field. Another consideration for our finding is that there may be a compensatory response in the WMZ that overcomes deficits only on particular tasks, or only for brief periods of time.
While compensatory responses are evident during sleep deprivation [23, 24, 60] , they are affected by cognitive domain, task complexity [14, 15] , and time on task [61, 62] . For example, tasks requiring long bouts of attention (>30 minutes) are associated with decreased thalamic activation [62] , while tasks requiring short bouts of attention show enhanced thalamic activation on functional magnetic resonance imaging (fMRI) [61] . While the extent to which compensatory responses are modulated by time of day remains unknown, our results may reflect the capacity to maintain performance due to a compensatory cerebral response unique to the WMZ. This speculation is supported by our previous work where, following 35 hours of sleep deprivation, there was no behavioral change in recognition memory on a short (360 s) task of verbal learning, yet compensatory responses, as indicated by increased frontal activation and additional recruitment from parietal areas, were observed [24] . We therefore pose an intriguing question as to whether the WMZ is more than simply an increased drive for alertness, but instead represents a biologically unique point in time that initiates a compensatory response to maintain cognitive function. This speculation echoes a recent novel finding describing changes in cortical excitability during the WMZ [63] . Cortical excitability reflects the equilibrium between excitatory and inhibitory neurons that allow for optimal cognitive function to occur. Increased excitability is associated with disease states (e.g. epilepsy, dementia, Attention Deficit Hyperactivity Disorder [ADHD]) and cognitive dysfunction [64] . Ly and colleagues showed that cortical excitability increased across the waking day but returned to a baseline value during the WMZ. Such was the strength of the association between cortical excitability, circadian phase and performance, the authors argued that cortical excitability represented a circadian mechanism by which performance was maintained at the end of the normal waking day. By this argument, the WMZ is more than simply a state of heightened alertness, but instead a time where cognitive systems are mostly intact, which is consistent with our findings. This hypothesis may also explain the plethora of studies showing cerebral compensatory responses on fMRI during the evening [14, 15, 20, 23, 24, 60] . The extent to which cortical excitability may become more stable in the WMZ during sleep deprivation, and the relationship that may have with fMRI signals, is however unknown.
Our study has a number of limitations and our results should be interpreted with these caveats. First, we tested a relatively small sample of healthy young adults, and thus our results may not be reflective of older adults, shift workers, or individuals with sleep disorders. Further research is needed to assess the generalizability of these results to clinical populations and operational contexts. Second, due to the small sample size we may have been underpowered to detect an effect during the WMZ. While our sample size is comparable to other studies utilizing this design and study outcomes [5, 8, 65, 66] , we corrected for multiple comparisons using a FDR, a less conservative method of correction, to reduce the potential for a type 1 error, plus we report effect sizes to support our findings: At 27 hours awake, we found moderate to large effect sizes for all outcomes, which indicates analyses were adequately powered, whereas for 37 hours awake effect sizes were large for vigilant attention outcomes, but small for other cognitive tests. A second possible limitation, inherent in study designs of this nature, was that our cognitive battery was always administered in the same order, and participants practiced the tasks only once before completing the tests during the CR. Previous research does not suggest there would be a strong learning effect with these tasks: In a sample of healthy young adults (comparable to our participants), no change was reported between a first and second administration of the tasks [67] , while studies of healthy older adults and clinical populations reported only mild improvement between the first and second administrations of the test battery, and stability in performance thereafter [33, 34, 68] . Our data (Figure 3 ) clearly shows the stability of performance between the second and third administrations of the task, at 3 hours and 13 hours (the first administration was on the first baseline day; Figure 1 ). Further, a learning effect would result in poorer performance at 3 hours, which would mask our reported finding that performance is impaired at 27 hours (fourth administration) relative to 3 hours (second administration). Based on our data and that of others we believe the single scheduled practice in our design was adequate to remove any learning effects from our data. The results of this study have several implications. First, given that we report time-specific changes in cognitive function during sleep deprivation, we suggest that a measure of circadian phase is necessary to appropriately interpret the impact of sleep deprivation on cognitive performance, especially if tests are scheduled in the evening. Healthy participants show a ~5-hour range in circadian phase after maintaining stable 8-hour sleep patterns for multiple weeks [69, 70] , while groups with more disrupted sleep patterns show even greater variability: for example, 7 hours in insomnia patients [71] and 12 hours in shift workers [72, 73] . Given the large majority of sleep and circadian studies schedule tests according to time since wake, differences in circadian phase of this magnitude could result in substantial variation in the circadian timing of cognitive assessment between participants. Second, we minimized the impact of task design on performance by using a battery comprising tasks that have comparable features, including task duration and visual presentation. Using tasks with similar features to assess different cognitive domains would enhance the comparability between studies, and may reduce the variance between studies reported as a limitation in meta-analytic approaches [2] . Third, the finding that performance on more complex cognitive tasks, particularly those assessing accuracy, is relatively preserved in the WMZ may be beneficial to shift working populations, such that tasks requiring accuracy might be best scheduled to occur during the WMZ during work schedules where sleep loss is inevitable. Finally, we found evidence of inter-individual variation in both circadian phase and cognitive performance. As we provide evidence for task-dependent and time-dependent effects in cognitive failure during sleep deprivation, identifying individuals at risk of cognitive failure, and the time at which they are most at risk, would represent a significant improvement in operational risk management where sleep loss remains common. Developing simplified methods of circadian phase to identify both periods of impairment and preserved cognitive function could therefore facilitate smart scheduling systems designed to maximize safety and productivity in the modern 24/7 workplace.
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